cycloheximide has been researched along with Leukemia, Megakaryocytic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuzumaki, N; Nakagawa, K | 1 |
| Fujita, H; Komatsu, N | 1 |
| Brown, KE; Kajigaya, S; Komatsu, N; Shimomura, S; Wong, S; Young, NS | 1 |
| Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG | 1 |
| Ryo, R; Yamaguchi, N; Yasunaga, M | 1 |
| Alitalo, K; Alitalo, R; Andersson, LC; Koskinen, P; Mäkelä, TP | 1 |
6 other study(ies) available for cycloheximide and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
Topics: Cells, Cultured; Cycloheximide; DNA-Binding Proteins; Down-Regulation; Genes, Reporter; HeLa Cells; Humans; Leukemia, Megakaryoblastic, Acute; Oncogene Proteins, Fusion; rhoA GTP-Binding Protein; Serum Response Factor; SUMO-1 Protein; Time Factors; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Two-Hybrid System Techniques; Ubiquitin-Conjugating Enzymes | 2005 |
Induced megakaryocytic maturation of the human leukemia cell line UT-7 results in down-modulation of erythropoietin receptor gene expression.
Topics: Cell Differentiation; Cycloheximide; Down-Regulation; Erythropoietin; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Receptors, Erythropoietin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Early and late gene expression in UT-7 cells infected with B19 parvovirus.
Topics: Base Sequence; Capsid; Cell Line; Cycloheximide; DNA Replication; DNA, Viral; Genes, Viral; Humans; Leukemia, Megakaryoblastic, Acute; Molecular Sequence Data; Parvovirus B19, Human; Promoter Regions, Genetic; RNA, Viral; Time Factors; Transcription, Genetic; Viral Proteins; Viral Structural Proteins | 1993 |
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Modulation of GM-CSF receptor beta-subunit and interleukin-6 receptor mRNA expression in a human megakaryocytic leukemia cell line.
Topics: Cell Differentiation; Cell Division; Cycloheximide; Gene Expression Regulation, Leukemic; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-3; Interleukin-6; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Platelet Membrane Glycoproteins; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Receptors, Immunologic; Receptors, Interleukin-6; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1992 |
Enhanced expression of transforming growth factor beta during megakaryoblastic differentiation of K562 leukemia cells.
Topics: Cell Line; Cell Transformation, Neoplastic; Cycloheximide; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Megakaryoblastic, Acute; Neoplasm Proteins; Peptide Biosynthesis; Peptides; Platelet-Derived Growth Factor; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transforming Growth Factors; Tumor Cells, Cultured | 1988 |